SQI Diagnostics Inc V.SQD.H

RE:Never any doubt - Just time - HUGE incentives

[25Stone7859]

Hey FF, this PR is more than two years old. It must be irrelevant by now. Since you know the Matthews, could you ask them  why HC and FDA submissions were never submitted even though TOR-dx validation was completed in Jan/2020? The SQI problem is lack of money. That is what should be discussed in these posts, not the products themselves that are undeniably important. Bringing up historical data from 2012 ,2018 and 2020 is just like speaking to the converted.  As a reminder, there is the possibility of a dark event occurence such as bankruptcy that is looming. As such, and hypothetically, Pivot and the three big Insiders as a whole could each claim 50% off the assets and either sell them off or restart the operation anew, possibly through an IPO or some such. But no one knows what is next.  The huge question everyone is asking is why the BoD and AM have not been able to fix this, even though the pipeline is so attractive. No one is biting. Yet these individuals have been so supportive over the years  and that cannot be denied, so it a surprise.There seems to be a big impediment somewhere in the mix that is turning off potential white knights.
SQI's track record to date has not been exemplary. Remember the BIG PHARMA experiment and even the recent PBI acquisition which is almost a negative with the latest Q1 results. So maybe SQI @ $0.045 is realistic given the disappointment and circumstances so far.